Issue |
Section |
Title |
File |
Vol 17, No 3 (2018) |
ORIGINAL ARTICLES |
Clinical experience using selective immunomodulating targeted therapy of Interstitial lymphocytic lung disease in a group of pediatric patients with primary immunodeficiencies |
 (Rus)
|
Vol 18, No 1 (2019) |
SCHOOL OF IMMUNOLOGY – EXPERT OPINION |
Lymphoma as a rare complication of severe combined immunodeficiency |
 (Rus)
|
Vol 19, No 3 (2020) |
ORIGINAL ARTICLES |
Haematological complications of X-linked lymphoproliferative syndrome type 1 and 2 |
 (Rus)
|
Vol 19, No 4 (2020) |
ORIGINAL ARTICLES |
Verification of X-linked lymphoproliferative syndrome type 1 and 2 using a flow cytometry method |
 (Rus)
|
Vol 19, No 4 (2020) |
CLINICAL OBSERVATIONS |
Epstein–Barr virus-associated smooth muscle tumors in patients with primary immunodeficiencies |
 (Rus)
|
Vol 19, No 4 (2020): supplement |
MATERIALS OF THE 3rd WORKING MEETING OF ALLERGISTS-IMMUNOLOGISTS |
Influence of clinical and immunophenotypic variants of severe combined immunodeficiency on severity and outcomes of opportunistic infections |
 (Rus)
|
Vol 19, No 4 (2020): supplement |
MATERIALS OF THE 3rd WORKING MEETING OF ALLERGISTS-IMMUNOLOGISTS |
The efficacy and safety of romiplostim in the treatment of thrombocytopenia in pediatric patients with Wiskott–Aldrich syndrome: the results of a retrospective study |
 (Rus)
|
Vol 19, No 4 (2020): supplement |
MATERIALS OF THE 3rd WORKING MEETING OF ALLERGISTS-IMMUNOLOGISTS |
Non-infectious complications in the group of pediatric patients with chronic granulomatous disease |
 (Rus)
|
Vol 19, No 4 (2020): supplement |
MATERIALS OF THE 3rd WORKING MEETING OF ALLERGISTS-IMMUNOLOGISTS |
Chromosomal aberrations as the cause of a complex phenotype in children with primary immunodeficiencies |
 (Rus)
|
Vol 20, No 3 (2021) |
SCHOOL OF IMMUNOLOGY – EXPERT OPINION |
Clinical case of type I interferonopathy: homozygous STAT2 gain-of-function mutation |
 (Rus)
|
Vol 21, No 1 (2022) |
ORIGINAL ARTICLES |
Cryopyrin-associated periodic syndrome assess the efficacy and safety of anakinra therapy: a single center experience |
 (Rus)
|
Vol 23, No 4 (2024) |
ORIGINAL ARTICLES |
An assessment of efficacy and safety of replacement therapy with subcutaneous immunoglobulin 16.5% administered by rapid push method in patients with inborn errors of immunity: the results of a prospective multicenter study |
 (Rus)
|